Current role
Former Chief
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Former Chief
The proxy statement of Indivior Pharmaceuticals, Inc. reports total compensation of $3,853,518 for Former Chief in fiscal 2024, including a base salary of $871,750. Disclosed compensation is on record for 2 fiscal years.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Indivior Pharmaceuticals, Inc. (INDV)
Proxy statement
Current
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Indivior Pharmaceuticals, Inc.
Other people whose current roles at this company are on record from its filings.
- Joe Ciaffoni CEO, Board Member
- Mark Crossley CEO
- Ryan Preblick CFO
- Barbara Ryan Board Member
- Daniel Ninivaggi Board Member
- Dr. David Wheadon Board Member
- Dr. Keith Humphreys Board Member
- Joseph Ciaffoni Board Member
- Juliet Thompson Board Member
- Mark Stejbach Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Indivior Pharmaceuticals, Inc. (INDV) | Executive Officer | $871,750 | $3,853,518 |
| 2023 | Indivior Pharmaceuticals, Inc. (INDV) | Executive Officer | $834,210 | $4,391,241 |
Recent activity
No call appearances or filed executive changes recorded yet.